

E154 - (CME) The Efficacy and Safety of VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia
Jul 27, 2022
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Introduction
00:00 • 3min
Drug Induce Parkinsonism
02:53 • 2min
Dopemin Induce Parkinsonism - What Is v Mat Two?
04:50 • 2min
Dopamine
06:23 • 2min
The History of Reserpine
08:21 • 2min
Tetrebenazine
10:24 • 3min
The Metabolites of Tetra Benazine and Dutetrebenizine
13:32 • 2min
Is It a Cosmatic Disorder?
15:14 • 2min
Dopemine Receptor Blocking - How Does It Help Diffuse Distinction?
17:20 • 3min
Dopamine Receptor Blocking
20:24 • 2min
Is Valbenazine Effective?
22:52 • 2min
What's the Difference Between a Zero and a 28?
24:54 • 2min
Dose of v Mat Inhibition in Pandemic Patients
26:59 • 2min
Psychiatry - Is There a Difference?
28:43 • 2min
Dosing of Benazine
30:23 • 2min
Dose of Valbenazine
32:20 • 2min
Valbenazine vs Dutetebenazin
34:10 • 2min
Dosage of Albenazine
36:12 • 2min
Is There Something I Need to Be Concerned About?
37:50 • 2min
The Side Effects of Valbenazine
39:39 • 2min
Dutetra Benazine - A Drug That Has to Be Traded
41:22 • 2min
Dutetra Benazine for Huntington's?
43:14 • 2min
Valbenazine and v Mato Inhibitors?
45:13 • 2min
Dosing Valbenazine for T D in Older People?
47:06 • 1min
Is It a Good Idea to Prescribe Inhibitor or Vimet?
48:34 • 2min
Is There Any Evidence That You Can Continue to See Improvement Over Time?
50:45 • 2min
Is There a Better Treatment for Td?
52:28 • 2min
How Do I Assess My Patience for Abnormal Movements?
54:25 • 2min
Do You Need to Do a Full Structure of Evaluation of a Patient on Anisacotic?
56:13 • 3min
Anticol Inergy Side Effects as We Get Older
58:55 • 2min
Do You Have a Cold Nergic?
01:00:41 • 3min